ProfileGDS4718 / 238446_at
TitleColorectal cancer: homogenized tumor tissues
OrganismHomo sapiens


no metastasis metastatic recurrence metastasis stage: 0 stage: 1 stage: 2a stage: 2b stage: 3b stage: 3c stage: 2a stage: 2b stage: 3b stage: 3c stage: 4 GSM549121 GSM549102 GSM549104 GSM549108 GSM549119 GSM549133 GSM549139 GSM549099 GSM549109 GSM549110 GSM549114 GSM549122 GSM549134 GSM549136 GSM549140 GSM549111 GSM549113 GSM549132 GSM549137 GSM549142 GSM549100 GSM549107 GSM549115 GSM549116 GSM549120 GSM549131 GSM549118 GSM549129 GSM549123 GSM549124 GSM549126 GSM549128 GSM549103 GSM549117 GSM549138 GSM549141 GSM549130 GSM549101 GSM549105 GSM549106 GSM549112 GSM549125 GSM549127 GSM549135 38% 40% 40% 41% 41% 39% 44% 35% 43% 39% 37% 45% 46% 42% 34% 38% 44% 48% 44% 52% 35% 41% 39% 37% 41% 41% 45% 47% 45% 41% 39% 41% 46% 39% 39% 46% 45% 43% 37% 36% 41% 43% 44% 42% sort by disease state sort by other Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM549121patient 080, normal, homogenized [OPG study]4.8870638
GSM549102patient 115, normal, homogenized [OPG study]5.007640
GSM549104patient 119, normal, homogenized [OPG study]5.0025740
GSM549108patient 138, normal, homogenized [OPG study]5.0969441
GSM549119patient 077, normal, homogenized [OPG study]5.0755341
GSM549133patient 032, cancer, homogenized [OPG study]4.9084839
GSM549139patient 042, cancer, homogenized [OPG study]5.1857244
GSM549099patient 107, normal, homogenized [OPG study]4.7796935
GSM549109patient 139, normal, homogenized [OPG study]5.1419843
GSM549110patient 046, normal, homogenized [OPG study]4.9671439
GSM549114patient 063, normal, homogenized [OPG study]4.8246237
GSM549122patient 082, normal, homogenized [OPG study]5.2557445
GSM549134patient 033, cancer, homogenized [OPG study]5.2977346
GSM549136patient 036, cancer, homogenized [OPG study]5.0374942
GSM549140patient 044, cancer, homogenized [OPG study]4.6770634
GSM549111patient 047, normal, homogenized [OPG study]4.8762938
GSM549113patient 057, normal, homogenized [OPG study]5.1493144
GSM549132patient 031, cancer, homogenized [OPG study]5.3718148
GSM549137patient 038, cancer, homogenized [OPG study]5.190944
GSM549142patient 047, cancer, homogenized [OPG study]5.7382852
GSM549100patient 110, normal, homogenized [OPG study]4.8074935
GSM549107patient 135, normal, homogenized [OPG study]4.9895441
GSM549115patient 068, normal, homogenized [OPG study]4.8986739
GSM549116patient 072, normal, homogenized [OPG study]4.8250237
GSM549120patient 078, normal, homogenized [OPG study]5.0414841
GSM549131patient 030, cancer, homogenized [OPG study]4.9983841
GSM549118patient 074, normal, homogenized [OPG study]5.2313245
GSM549129patient 027, cancer, homogenized [OPG study]5.3450647
GSM549123patient 088, normal, homogenized [OPG study]5.2302745
GSM549124patient 006, cancer, homogenized [OPG study]5.0850241
GSM549126patient 015, cancer, homogenized [OPG study]4.9605239
GSM549128patient 025, cancer, homogenized [OPG study]5.0124241
GSM549103patient 117, normal, homogenized [OPG study]5.3373346
GSM549117patient 073, normal, homogenized [OPG study]4.8907339
GSM549138patient 041, cancer, homogenized [OPG study]4.9118339
GSM549141patient 045, cancer, homogenized [OPG study]5.2245746
GSM549130patient 028, cancer, homogenized [OPG study]5.2322145
GSM549101patient 111, normal, homogenized [OPG study]5.148843
GSM549105patient 128, normal, homogenized [OPG study]4.8610637
GSM549106patient 134, normal, homogenized [OPG study]4.7395836
GSM549112patient 048, normal, homogenized [OPG study]5.0479141
GSM549125patient 011, cancer, homogenized [OPG study]5.1689743
GSM549127patient 024, cancer, homogenized [OPG study]5.2153444
GSM549135patient 035, cancer, homogenized [OPG study]5.0528942